Latent autoimmune diabetes in adults in Asians: Similarities and differences between East and West

Journal of Diabetes

Volumn 5, Issue 2, 2013, Pages 118-126

  Xiang, Yufei ^a   Zhou, Zhiguang ^a   Deng, Chao ^a   Leslie, Richard D ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Asians; Caucasians; Ethnic differences; Latent autoimmune in adults (LADA)

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSCRIPTION FACTOR 7 LIKE 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY TITER; ASIAN; BODY MASS; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIABETES MELLITUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMMUNOGENICITY; INSULIN RESISTANCE; LATENT AUTOIMMUNE DIABETES IN ADULT; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; VARIABLE NUMBER OF TANDEM REPEAT;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 84877082246     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12029     Document Type: Review

References (63)

1. Leslie RD, Kolb H, Schloot NC etal. Diabetes classification: Grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev. 2008; 24: 511-519.
2. Fourlanos S, Dotta F, Greenbaum CJ etal. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005; 48: 2206-2212.
3. Buzzetti R, Di Pietro S, Giaccari A etal. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care. 2007; 30: 932-938.
4. Petrone A, Suraci C, Capizzi M etal. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care. 2008; 31: 534-538.
5. Tiberti C, Giordano C, Locatelli M etal. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) study 2. Diabetes. 2008; 57: 1276-1283.
6. Lampasona V, Petrone A, Tiberti C etal. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care. 2009; 33: 104-108.
7. Zampetti S, Spoletini M, Petrone A etal. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5Diabet Med. 2010; 27: 701-704.
8. Zampetti S, Capizzi M, Spoletini M etal. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD Study 6J Clin Endocrinol Metab. 2012; 97: 3759-3765.
9. Olsson L, Ahlbom A, Grill V, Midthjell K, Carlsson S. Sleep disturbances and low psychological well-being are associated with an increased risk of autoimmune diabetes in adults. Results from the Nord-Trondelag Health Study. Diabetes Res Clin Pract. 2012; 98: 302-311.
10. Pettersen E, Skorpen F, Kvaloy K, Midthjell K, Grill V. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: Results from the Nord-Trondelag Health Study. Diabetes. 2009; 59: 302-310.
11. Radtke MA, Lund Nilsen TI, Midthjell K, Grill V. Urinary albumin excretion in latent autoimmune diabetes in adults (LADA) is more similar to type 2 than type 1 diabetes: Results of the Nord-Trondelag Health Study 1995-1997. Diabetes Metab. 2009; 35: 273-279.
12. Radtke MA, Midthjell K, Nilsen TI, Grill V. Heterogeneity of patients with latent autoimmune diabetes in adults: Linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: Results from the Nord-Trondelag Health (HUNT) study. Diabetes Care. 2009; 32: 245-250.
13. Rasouli B, Ahlbom A, Andersson T etal. Alcohol consumption is associated with reduced risk of Type 2 diabetes and autoimmune diabetes in adults: Results from the Nord-Trondelag health study. Diabet Med. 2012; 30: 56-64.
14. Sorgjerd EP, Skorpen F, Kvaloy K, Midthjell K, Grill V. Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: The HUNT study, Norway. Diabetologia. 2012; 55: 1310-1318.
15. Sorgjerd EP, Skorpen F, Kvaloy K, Midthjell K, Grill V. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes. Results from the HUNT study, Norway. Autoimmunity. 2012; 46: 74-79.
16. Turner R, Stratton I, Horton V etal. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997; 350: 1288-1293.
17. Horton V, Stratton I, Bottazzo GF etal. Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43UK Prospective Diabetes Study (UKPDS) Group. Diabetologia. 1999; 42: 608-616.
18. Bottazzo GF, Bosi E, Cull CA etal. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71Diabetologia. 2005; 48: 703-708.
19. Desai M, Cull CA, Horton VA etal. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia. 2007; 50: 2052-2060.
20. Desai M, Clark A. Autoimmune diabetes in adults: Lessons from the UKPDS. Diabet Med. 2008; 25 (Suppl. 2): 30-34.
21. Brophy S, Yderstraede K, Mauricio D etal. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care. 2008; 31: 439-441.
22. Hawa MI, Thivolet C, Mauricio D etal. Metabolic syndrome and autoimmune diabetes: Action LADA 3. Diabetes Care. 2009; 32: 160-164.
23. Pham MN, Hawa MI, Pfleger C etal. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia. 2011; 54: 1630-1638.
24. Pham MN, Hawa MI, Roden M etal. Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5. Diabet Med. 2011; 29: 470-478.
25. Strom A, Menart B, Simon MC etal. Cellular interferon-gamma and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: Action LADA 6. Cytokine. 2012; 58: 148-151.
26. Hawa MI, Kolb H, Schloot N etal. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care. 2012; PMID: 2324819 [Epub ahead of print].
27. Park Y, Hong S, Park L etal. LADA prevalence estimation and insulin dependency during follow-up. Diabetes Metab Res Rev. 2011; 27: 975-979.
28. Takeda H, Kawasaki E, Shimizu I etal. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime StudyDiabetes Care. 2002; 25: 995-1001.
29. Murao S, Kondo S, Ohashi J etal. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA): A 5-year follow-up of the Ehime study. Diabetes Res Clin Pract. 2008; 80: 114-121.
30. Zhou Z, Xiang Y, Ji L etal. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in china (LADA China Study): A nationwide, multicenter, clinic-based cross-sectional study. Diabetes. 2013; 62: 543-550.
31. Zhou Z, Ouyang L, Peng J etal. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults. Chin Med J. 1999; 112: 554-557.
32. Li X, Zhou ZG, Haung G etal. Study on the postive frequency and distribution of glutamic acid decarboxylase antibody in phenotypic type 2 diabetec patients. Zhonghua Liu Xing Bing Xue Za Zhi. 2005; 26: 800-803 (in Chinese
33. Qi X, Sun J, Wang J etal. Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: A population-based cross-sectional study. Diabetes Care. 2010; 34: 66-70.
34. Tuomi T, Carlsson A, Li H etal. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999; 48: 150-157.
35. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000; 23: 1516-1526.
36. Xiang Y, Zhou P, Li X etal. Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China. Diabetes Care. 2011; 34: 1639-1641.
37. Li X, Zhou Z, Huang G, Su H, Yan X, Yang L. Metabolic syndrome in adult-onset latent autoimmune diabetes. Metab Syndr Relat Disord. 2005; 3: 174-180.
38. Chiu HK, Tsai EC, Juneja R etal. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Diabetes Res Clin Pract. 2007; 77: 237-244.
39. Zimmet P. Antibodies to glutamic acid decarboxylase in the prediction of insulin dependency. Diabetes Res Clin Pract. 1996; 34 (Suppl.) S125-131.
40. Li X, Yang L, Zhou Z, Huang G, Yan X. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults. Chin Med J. 2003; 116: 1728-1732.
41. Knip M. Natural course of preclinical type 1 diabetes. Horm Res. 2002; 57 (Suppl. 1): 6-11.
42. Huang G, Wang X, Li Z, Li H, Li X, Zhou Z. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol. 2010; 49: 327-331.
43. Yang L, Luo S, Huang G etal. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev. 2010; 26: 579-584.
44. Wenzlau JM, Juhl K, Yu L etal. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type l diabetes. Proc Natl Acad Sci USA. 2007; 104: 17040-17045.
45. Mannering SI, Wong FS, Durinovic-Belló I etal. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin Exp Immunol. 2010; 162: 197-209.
46. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes. Diabetes. 2007; 56: 2110-2115.
47. Zhang Y, Zhou ZG, Yang L, Lin J, Li X, He WM. Abnormal T cell autoimmunity against GAD65 in LADA patients. Zhonghua Yi Xue Za Zhi. 2010; 90: 1963-1965 (in Chinese
48. Yang Z, Zhou Z, Huang G etal. The CD4(+) regulatory T-cells is decreased in adults with latent autoimmune diabetes. Diabetes Res Clin Pract. 2007; 76: 126-131.
49. Gambelunghe G, Forini F, Laureti S etal. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol. 2000; 52: 565-573.
50. Jin P, Zhou ZG, Yang L etal. Adult-onset latent autoimmune diabetes and autoimmune thyroid disease. Zhonghua Nei Ke Za Zhi. 2004; 43: 363-367 (in Chinese
51. Jin P, Huang G, Lin J etal. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clin Endocrinol. 2011; 74: 587-592.
52. Jin P, Huang G, Lin J, Luo S, Zhou Z. Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity. Acta Diabetol. 2011; 48: 149-155.
53. Maioli M, Pes GM, Delitala G etal. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol. 2010; 163: 541-549.
54. Liu F, Liu J, Zheng TS etal. The -1123G>C variant of PTPN22 gene promoter is associated with latent autoimmune diabetes in adult Chinese Hans. Cell Biochem Biophys. 2011; 62: 273-279.
55. Lin J, Zhou ZG, Wang JP, Zhang C, Huang G. From type 1, through LADA, to type 2 diabetes: A continuous spectrum? Ann N Y Acad Sci. 2008; 1150: 99-102.
56. Kawasaki E, Eguchi K. Is type 1 diabetes in the Japanese population the same as among Caucasians? Ann N Y Acad Sci. 2004; 1037: 96-103.
57. Bakhtadze E, Cervin C, Lindholm E etal. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia. 2008; 51: 2224-2232.
58. Cervin C, Lyssenko V, Bakhtadze E etal. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes. 2008; 57: 1433-1437.
59. Szepietowska B, Moczulski D, Wawrusiewicz-Kurylonek N, Grzeszczak W, Gorska M, Szelachowska M. Transcription factor 7-like 2-gene polymorphism is related to fasting C peptide in latent autoimmune diabetes in adults (LADAActa Diabetol. 2009; 47: 83-86.
60. Lukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: A meta-analysis and an individual study. Diabetologia. 2011; 55: 689-693.
61. Qiao H, Zhang X, Zhao X etal. Genetic variants of TCF7L2 are associated with type 2 diabetes in a northeastern Chinese population. Gene. 2012; 495: 115-119.
62. Abiru N, Kawasaki E, Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab Res Rev. 2002; 18: 357-366.
63. Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: The Fremantle Diabetes Study. Diabet Med. 2000; 17: 667-674.